Pfizer's compensation case focuses on hypertension in black people
KINGSTON, Jamaica — The Supreme Court yesterday began exploring the management of hypertension (blood pressure) among black people, as it continued its search for a solution to the compensation issue involving local pharmaceutical distributors Lasco and Medimpex, and global drug giant Pfizer.
We process personal data about users of our site, through the use of cookies and other technologies, to deliver our services, personalize advertising, and to analyze site activity. We may share certain information about our users with our advertising and analytics partners. For additional details, refer to our Privacy Policy.
By clicking "I AGREE" below, you agree to our Privacy Policy and our personal data processing and cookie practices as described therein. You also acknowledge that this forum may be hosted outside your country and you consent to the collection, storage, and processing of your data in the country where this forum is hosted.